Ardelyx (ARDX) Revenue Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.37% |
| Dec 31, 2025 | 133.37% |
| Sep 30, 2025 | 4.62% |
| Jun 30, 2025 | 121.40% |
| Mar 31, 2025 | 127.62% |
| Dec 31, 2024 | 120.07% |
| Sep 30, 2024 | 100.75% |
| Jun 30, 2024 | 427.08% |
| Dec 31, 2023 | 232.15% |
| Sep 30, 2023 | 218.52% |
| Jun 30, 2023 | 275.29% |
| Mar 31, 2023 | 37.42% |
| Jun 30, 2020 | -36.75% |
| Mar 31, 2020 | -27.08% |
| Dec 31, 2019 | -18.71% |
| Sep 30, 2019 | -16.89% |
| Jun 30, 2019 | -71.23% |
| Dec 31, 2018 | -60.18% |
| Sep 30, 2018 | -51.77% |
| Jun 30, 2018 | -66.67% |